RGD peptide GRGDNP(2TFA)

CAS No. 114681-65-1

RGD peptide GRGDNP(2TFA) ( —— )

Catalog No. M21027 CAS No. 114681-65-1

RGD peptide GRGDNP(2TFA) is a integrin-ligand interactions?inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 Get Quote
5MG 65 Get Quote
10MG 105 Get Quote
25MG 215 Get Quote
50MG 320 Get Quote
100MG 474 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RGD peptide GRGDNP(2TFA)
  • Note
    Research use only not for human use.
  • Brief Description
    RGD peptide GRGDNP(2TFA) is a integrin-ligand interactions?inhibitor.
  • Description
    RGD peptide GRGDNP(2TFA) is a integrin-ligand interactions?inhibitor.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    114681-65-1
  • Formula Weight
    614.61
  • Molecular Formula
    C23H38N10O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=C(N)NCCCC(NC(=O)CN)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC(N)=O)C(=O)N1CCCC1C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang W Lin Q Guan J L et al. Activation of the Cdc42-associated Tyrosine Kinase-2 (ACK-2) by Cell Adhesion via Integrin 1[J]. Journal of Biological Chemistry 1999 274(13):8524-8530.
molnova catalog
related products
  • ML165

    A high-affinity, selective platelet integrin αIIbβ3 receptor antagonist with IC50 of 96 nM.

  • GSK-3008348

    GSK-3008348 is a novel potent, selective integrin αvβ6 antagonist for the treatment of idiopathic pulmonary fibrosis (IPF).

  • Cyclo(RGDfK)

    Cyclo (-RGDfK) is a potent and selective αvβ3 integrin inhibitor.